This is the authors' abstract. We don't add key points for this paper.
Insulin gene (INS) mutations prove to be the second most common cause of permanent neonatal diabetes. Here, we report the generation of iPSC line from a patient, heterozygous for the intronic INS mutation that presumably leads to aberrant splicing. Dermal fibroblasts were reprogrammed using non-integrating RNA-based vector. Derivation and expansion of iPSCs were performed under feeder-free culture conditions. The iPSC line expressed pluripotency markers, had normal karyotype, could differentiate into three germ layers in vitro and retained the disease mutation. This line can be a powerful tool for modeling of diabetes and cell replacement therapy as well.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Panova et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: